Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a pulse add-on in HBeAg-negative chronic hepatitis B on long-term nucleos(t)ide therapy
2014-003894-41Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Start
- Oct 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of interferon alfa in hepatitis B (HBV) (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Parma. Primary endpoint: Strength and quality of HBV-specific T cell responses at week 24. Started Oct 2014; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2014-003894-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003894-41.